Health Condition 1: L509- Urticaria, unspecified
Conditions
Interventions
Intervention1: nil: nil
Control Intervention1: nil: nil
Sponsors
Father Muller research centre
Eligibility
Inclusion criteria
Inclusion criteria: Non-smokers Patients diagnosed with active chronic spontaneous urticaria of more than or equal to 6 weeks duration.
Exclusion criteria
Exclusion criteria: 1. The subjects should not have taken oral corticosteroids or other immunosuppressive drugs in the last 8 weeks or antihistamines at least within 4 days before the day of assessment. 2. Patients with known complement deficiencies, recent trauma (
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| With this study, we may be able to indicate the role of complement proteins, C3 & C4 in the pathogenesis of CSU & assess its role in the prognosis of the disease severity. The knowledge derived from this study can help us develop a treatment system that caters to the severity of the disease process & further develop newer treatment options targeting C3, C4, which could be a promising option for the treatment of CSU. Timepoint: one year | — |
Secondary
| Measure | Time frame |
|---|---|
| The knowledge derived from this study can help us develop a treatment system that caters to the severity of the disease process & further develop newer treatment options targeting C3, C4, which could be a promising option for the treatment of CSU.Timepoint: 10 years | — |
Countries
India
Contacts
Public ContactDr Swathi N
Father Muller Medical College
Outcome results
None listed